Dimensional Fund Advisors LP In8 Bio, Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
SELL
$1.05 - $3.24 $7,243 - $22,352
-6,899 Reduced 28.18%
17,583 $27,000
Q1 2023

May 12, 2023
BUY
$1.17 - $2.83 $15,594 - $37,721
13,329 Added 119.51%
24,482 $31,000
Q4 2022

Feb 09, 2023
BUY
$1.39 - $2.47 $15,502 - $27,547
11,153 New
11,153 $25,000

Others Institutions Holding INAB

# of Institutions
27
Shares Held
7.62M
Call Options Held
0
Put Options Held
0
View Full List

About IN8BIO, INC.

INAB Quotes by TradingView
  • Ticker INAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,502,200
  • Market Cap $6.13M
  • Description
  • IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...
More about INAB
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email